valine and Generalized Resistance to Thyroid Hormone

valine has been researched along with Generalized Resistance to Thyroid Hormone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrne, MM; Marinov, VS; Refetoff, S; Sunthornthepvarakul, T; Tunca, H; Weiss, RE1
Adams, M; Cavaillès, V; Chatterjee, VK; Collingwood, TN; Fletterick, RJ; Kalkhoven, E; Lindstedt, G; Matthews, C; Nystrom, E; Parker, MG; Rajanayagam, O; Stenlof, K; Tisell, L; Wagner, R1

Other Studies

2 other study(ies) available for valine and Generalized Resistance to Thyroid Hormone

ArticleYear
A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:9

    Topics: Adolescent; Adult; Aged; Base Sequence; Diagnosis, Differential; Female; Humans; Hyperthyroxinemia; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Prealbumin; Thyroid Hormone Resistance Syndrome; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse; Valine

1996
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Jan-07, Volume: 94, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Adult; Binding Sites; Dimerization; DNA-Binding Proteins; Genes, Reporter; Histone Acetyltransferases; Humans; Leucine; Models, Molecular; Mutation; Nuclear Proteins; Nuclear Receptor Coactivator 1; Nuclear Receptor Interacting Protein 1; Protein Binding; Receptors, Thyroid Hormone; Recombinant Proteins; Syndrome; Thyroid Hormone Resistance Syndrome; Thyroid Hormones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Valine

1997